top of page

Our research

Research themes

Our research efforts cover five key research themes.


Clinical toxicology and pharmacology


Aboriginal and other priority populations

Alcohol biology and genetics


Addiction treatment


Illicit drug use

Co-location of our members across the University of Sydney and Sydney Local Health District uniquely positions the Edith Collins Centre to conduct research focused on clinical integration and research translation.

Our work is aligned with state and national priorities in health, social justice and community. It recognises the importance of addressing the impacts and harms of substance use, while also driving policy and system change to
reduce health inequities and improve overall health outcomes.

Research priorities

As we work to increase clinical research capacity in the fields of alcohol, drugs and toxicology, the Edith Collins Centre focuses on:

  • providing research infrastructure support for large-scale collaborative research activities, including clinical trials

  • conducting patient-centred translational research dedicated to improving health

  • developing a sustainable funding model by supporting bids for national and international funding and philanthropic support

  • attracting and supporting the most outstanding researchers and  clinical academics

  • maintaining robust research governance to ensure the highest safety, integrity and quality 

  • implementing an effective communication strategy to raise the profile of the research and clinical work in order to influence policy decisions, facilitate research translation and raise public awareness.

Recent achievements

In 2021, we had over 120 publications in peer-reviewed journals

In 2021, we mentored and trained 26 higher degree research students

Over the past 5 years (2017-2021), we’ve attracted over
$34 million 
of grant and fellowship funding

Over the past 5 years, our members have presented over 200 national and international conference papers


New grants commencing in 2022, worth over $9.5 million

  • 2022-2025 – MRFF Innovative Therapies for Mental Illness - A randomised, double-blind, controlled trial of MDMA assisted exposure therapy for comorbid alcohol use and post-traumatic stress disorder. $1,951,246. CIA. Awardees: Morley, Mills, Haber, Lubman, Teesson, Arunogiri, Baillie, Yong Yi Lee, Morse,  Back

  • 2022-2026 – NHMRC Synergy Grant - Linking clinical and basic science discovery to find new treatments for alcohol use disorder. $5,000,000. CIB. Awardees: Haber, Morley, Lawrence, Manning, Lubman, McNally, Millan, Arunogiri

  • 2022-2026 – NHMRC Investigator Grant Level 3 - Applied research to prevent the epidemic of poisoning deaths. $1,500,000. Awardee: Buckley NA

  • 2022- 2026 – NHMRC Investigator Grant, Emerging Leadership 1. Alcohol treatment for Aboriginal men in and out of prison $607,263. Awardee: Doyle, M

  • 2022-2024 – ARC Discovery Project. Investigating Memory Reliability in Intoxicated Witnesses of Crime. $525,427. Awardees: Monds, Takarangi, Chin, Montebello; PIs: Semrad, Flowe

bottom of page